On 27 May 2021, the first National Investigator Meeting of the "Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial 4" (INTERACT4) was held online, co-organised by the George Institute for Global Health (China), Shanghai East Hospital of Tongji University and the First Affiliated Hospital of Chengdu Medical College. Participants included all co-Principal Investigators (PI) of the project: Professors Craig Anderson (the George Institute for Global Health China), Li Gang (Shanghai Oriental Hospital), and Yang Jie (The First Affiliated Hospital of Chengdu Medical College), together with other key members of the Steering Committee: Director Zhang Chunfang from Shanghai Pudong Medical Emergency Centre, Vice-President Wu Xiangjun from Guanghan People's Hospital, Director Xu Ping from Zigong the Fourth People's Hospital, and Head of INTERACT4 Coordination Centre Ms Yang Zhao (Stroke Section of The George Institute China), as well as site PIs and key research staff cross China.
The Lancet Regional Health - Western Pacific has recently accepted a review of China's healthy ageing policies led by Mao-Yi Tian, a senior researcher at the George Institute for Global Health (China). The study is the first of its kind to use an overview methodology to systematically analyse national policies on healthy ageing in China during the 13th Five-Year Plan period (2016 - 2020). It also for the first time compiles a detailed list of public policy database in China, and summarises the types, transmission direction, advice strength, and formulation purpose of policy documents in China, providing important research elements for future academic studies in this area.
The second academic steering committee and international advisory board meeting of the INTERACT4 (Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial 4), jointly sponsored by the George Institute for Global Health (China), Shanghai East Hospital of Tongji University and the First Affiliated Hospital of Chengdu Medical College, was held online recently. After reviewing the safety data, the Data Safety Monitoring Board (DSMB) recommended that the project proceed as planned and concluded that this potential life-saving program to initiate pre-hospital blood pressure lowering for patients with acute stroke in the emergency vehicle is feasible in China.